Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Shethal Bearelly
Associate Professor, Otolaryngology (Clinical Scholar Track)
Otolaryngology
Map Page
Research Area
cancer,
surgery,
oncology,
immunotherapy,
clinical trial,
robotic surgery,
case report,
oral health,
cancer treatment,
lymphoma
Publications
(19)
Recent
Randomized Phase II Trial of Ficlatuzumab with or without Cetuximab in pan-refractory, recurrent/metastatic head and neck cancer.
2023
cancer,
drug therapy,
immunotherapy,
clinical trial,
biological therapy
Comparison of margins and survival between transoral robotic surgery TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
2023
head and neck cancer,
robotic surgery,
surgical outcomes,
medical technology,
cancer treatment
Association of Perioperative Complications with Vitamin D Levels in Major Head and Neck Surgery
2022
vitamin d,
perioperative complications,
head and neck surgery,
association,
major surgery
The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.
2022
cancer,
healthcare access,
socioeconomic factors,
geographic factors,
surgery
Impact of Close Margins in Head and Neck Mucosal Squamous Cell Carcinoma: A Systematic Review
2021
cancer,
treatment,
clinical,
oncology,
review
Unilateral Cysticercosis of the Parotid Gland: Case report, diagnosis and clinical management
2021
infectious diseases,
parotid gland,
case report,
clinical management,
diagnosis
Interprting microscopic positive margins in differentiated thyroid cancer.
2021
cancer,
thyroid,
pathology,
surgery,
microscopy
Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma HNSCC)
2021
cancer,
immunotherapy,
clinical trial,
targeted therapy,
drug combination
Mucosa-associated lymphoid tissue lymphoma of the larynx
2020
lymphoma,
larynx,
tissue,
lymphoid
Randomized, phase II study of ficlatuzumab with or without cetuximab in patients with pan-refractory, recurrent/metastatic R/M) head and neck squamous cell carcinoma HNSCC)
2020
cancer,
immunotherapy,
clinical trial,
targeted therapy,
biological drugs
Collaborations
(9)
Denise Roe
Mutual work: 1 Publication
Collaboration Details
Charles Hsu
Mutual work: 1 Publication
Collaboration Details
Eugene Chang
Mutual work: 1 Proposal
Collaboration Details
Steven Wang
Mutual work: 1 Proposal
Collaboration Details
Sara Centuori
Mutual work: 1 Publication
Collaboration Details
Page 1 of 2
Previous page
Next page
8+ Collaborators
10+ Publications
